Suchbegriffe: TICLOPIDINE - ADVERSE EFFECTS , . Treffer: 5
Tscharre, M; Egger, F; Machata, M; Rohla, M; Michael, N; Neumayr, M; Zweiker, R; Hajos, J; Adlbrecht, C; Suppan, M; Helmreich, W; Eber, B; Huber, K; Weiss, TW
Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registry.
PLoS One. 2017; 12(6):e0179349-e0179349
Doi: 10.1371/journal.pone.0179349
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Trana, C; Toth, G; Wijns, W; Barbato, E
St. John's Wort in patients non-responders to clopidogrel undergoing percutaneous coronary intervention: a single-center randomized open-label trial (St. John's Trial).
J Cardiovasc Transl Res. 2013; 6(3):411-414
Doi: 10.1007/s12265-013-9455-2
Web of Science
PubMed
FullText
FullText_MUG
Metzler, H; Prüller, F; Münch, A; Primus, G; Kainz, J; Hödl, R; Rehak, P
Premature preoperative discontinuation of antiplatelet drug therapy in cardiovascular risk patients: a preliminary study on the role of P2Y12 receptor monitoring.
Eur J Anaesthesiol. 2010; 27(2):138-145
Doi: 10.1097/EJA.0b013e32832eb521
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Sacco, RL; Diener, HC; Yusuf, S; Cotton, D; Ounpuu, S; Lawton, WA; Palesch, Y; Martin, RH; Albers, GW; Bath, P; Bornstein, N; Chan, BP; Chen, ST; Cunha, L; Dahlöf, B; De Keyser, J; Donnan, GA; Estol, C; Gorelick, P; Gu, V; Hermansson, K; Hilbrich, L; Kaste, M; Lu, C; Machnig, T; Pais, P; Roberts, R; Skvortsova, V; Teal, P; Toni, D; Vandermaelen, C; Voigt, T; Weber, M; Yoon, BW; PRoFESS Study Group
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
N Engl J Med. 2008; 359(12):1238-1251
Doi: 10.1056/NEJMoa0805002
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Haushofer, A; Halbmayer, WM; Prachar, H
Neutropenia with ticlopidine plus aspirin.
Lancet. 1997; 349(9050):474-475
Doi: 10.1016/S0140-6736(05)61186-5
Web of Science
PubMed
FullText
FullText_MUG